Oleoylethanolamide (OEA), a bioactive lipid in bone, is known as an endogenous ligand for G protein-coupled receptor 119 (GPR119). Here, we explored the effects of OEA on osteoclast differentiation, function, and survival. While OEA inhibits osteoclast resorptive function by disrupting actin cytoskeleton, it does not affect receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast differentiation. OEA attenuates osteoclast spreading, blocks actin ring formation, and eventually impairs bone resorption. Mechanistically, OEA inhibits Rac activation in response to macrophage colony-stimulating factor (M-CSF), but not RANKL. Furthermore, the OEA-mediated cytoskeletal disorganization is abrogated by GPR119 knockdown using small hairpin RNA (shRNA), indicating that GPR119 is pivotal for osteoclast cytoskeletal organization. In addition, OEA induces apoptosis in both control and GPR119 shRNAtransduced osteoclasts, suggesting that GPR119 is not required for osteoclast apoptosis. Collectively, our findings reveal that OEA has inhibitory effects on osteoclast function and survival of mature osteoclasts via GPR119-dependent and GPR119-independent pathways, respectively.
Keywords: G protein-coupled receptor 119; apoptosis; cytoskeleton; oleoylethanolamide; osteoclast.
G protein-coupled receptor 119 is involved in RANKL-induced osteoclast differentiation and fusion.J Cell Physiol. 2019 Jul;234(7):11490-11499. doi: 10.1002/jcp.27805. Epub 2018 Nov 27. J Cell Physiol. 2019. PMID: 30478996
A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts.Mol Cells. 2014 Aug;37(8):598-604. doi: 10.14348/molcells.2014.0153. Epub 2014 Aug 18. Mol Cells. 2014. PMID: 25134536 Free PMC article.
G Protein-Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function.J Cell Physiol. 2016 Apr;231(4):844-51. doi: 10.1002/jcp.25133. Epub 2015 Sep 1. J Cell Physiol. 2016. PMID: 26280807
Osteoclasts: New Insights.Bone Res. 2013 Mar 29;1(1):11-26. doi: 10.4248/BR201301003. eCollection 2013 Mar. Bone Res. 2013. PMID: 26273491 Free PMC article. Review.
Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.Adv Drug Deliv Rev. 2005 May 25;57(7):959-71. doi: 10.1016/j.addr.2004.12.018. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876398 Review.